RESUMO
The role of interleukin-6 (IL-6) as a risk factor for developing depressive symptoms, neuropsychological impairment, and related functional and neurological symptom severity during the acute phase of ischemic stroke is still underexplored. Here, the authors assessed this issue, in 48 patients without significant clinical history for major medical illnesses or other factors that promote inflammation, 72 hours after a first-ever acute ischemic stroke. In the acute phase of ischemic stroke, increased IL-6 plays a key role in the onset of depressive disorders, apathy/amotivation, somatic symptoms of depression, and neurological/functional symptoms, resulting in higher disability and poor outcome of stroke patients.
Assuntos
Depressão/complicações , Interleucina-6/sangue , Acidente Vascular Cerebral/sangue , Acidente Vascular Cerebral/psicologia , Avaliação de Sintomas , Idoso , Biomarcadores/sangue , Isquemia Encefálica/sangue , Isquemia Encefálica/complicações , Isquemia Encefálica/psicologia , Depressão/sangue , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Escalas de Graduação Psiquiátrica , Índice de Gravidade de Doença , Acidente Vascular Cerebral/complicaçõesRESUMO
Different types of migraine have been reported in 20-40% of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We describe a novel migrainous manifestation of CADASIL consisting in status migrainosus and persistent aura without infarction. The symptoms resolved after i.v. treatment with lorazepam and mannitol.
Assuntos
CADASIL/complicações , CADASIL/fisiopatologia , Transtornos de Enxaqueca/etiologia , Transtornos de Enxaqueca/fisiopatologia , Enxaqueca com Aura/fisiopatologia , Adulto , Anticonvulsivantes/administração & dosagem , CADASIL/diagnóstico , Diuréticos Osmóticos/administração & dosagem , Feminino , Humanos , Injeções Intravenosas , Lorazepam/administração & dosagem , Manitol/administração & dosagem , Transtornos de Enxaqueca/tratamento farmacológico , Enxaqueca com Aura/tratamento farmacológico , Resultado do TratamentoRESUMO
There are few data on neuropsychological deficits in young-adult stroke patients. This study investigates cognitive conditions in a young-adult stroke population, as well as tasks that detect their neuropsychological impairment. Forty 18- to 47-year-old stroke patients, and a matched control group, completed a neuropsychological battery to evaluate deficits related to cognition, daily activities and mood. Patients performed worse than controls; five patients were classified as demented, three had global cognitive impairment and eight partial cognitive impairment. Cognitive impairment was more closely associated with reduced performance of daily activities than with motor deficits.
Assuntos
Afasia/diagnóstico , Infarto Cerebral/psicologia , Transtornos Cognitivos/diagnóstico , Testes Neuropsicológicos/estatística & dados numéricos , Atividades Cotidianas/psicologia , Adolescente , Adulto , Afasia/etiologia , Afasia/psicologia , Dano Encefálico Crônico/diagnóstico , Dano Encefálico Crônico/psicologia , Infarto Cerebral/diagnóstico , Infarto Cerebral/etiologia , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/psicologia , Feminino , Humanos , Masculino , Memória de Curto Prazo , Entrevista Psiquiátrica Padronizada/estatística & dados numéricos , Pessoa de Meia-Idade , Psicometria/estatística & dados numéricos , Reprodutibilidade dos Testes , Retenção Psicológica , Fatores de Risco , Ajustamento SocialRESUMO
Stroke has been shown to lead to depressive disorders, anxiety disorders and other emotional consequences. Although the cause of these disorders is a subject of debate, stroke has clearly been shown to lead to the production of pro-inflammatory cytokines, which we hypothesized to play a role in the production of post-stroke emotional disorders. Thus we investigated here whether acute stroke might be associated with changes in the normal serum levels of IL-18 and if these changes were related to stroke severity, as well as to the presence and severity of alexithymia and depression. Thirty patients with a first-ever symptomatic ischemic stroke were included. Alexithymia (Toronto Alexithymia Scale; TAS-20), depression (Hamilton Depression Rating Scale; HDRS-17) and serum IL-18 were assessed. Stroke patients showed serum levels of IL-18 significantly related to stroke severity. Furthermore, a strong positive correlation was observed between IL-18 levels and severity of alexithymia, particularly among patients with right-hemisphere lesions. Specifically, circulating concentrations of IL-18 were significantly increased in patients with categorical alexithymia (TAS-20 score 61), as compared with both non alexithymic patients and control subjects. In addition, stroke was more severe in alexithymic patients, as compared to non alexithymic patients. Following multivariate regression, serum IL-18 levels appeared to be specifically associated with alexithymia rather than with stroke severity in patients with right-hemisphere lesions only. These results suggest that IL-18 might be specifically implicated in the pathogenesis of post-stroke alexithymia, ultimately contributing to impaired recovery from stroke.